The Evaluation and Comparison of BCR-ABL p210 mRNA Transcripts (%IS Unit) Results Between Dr. PCR™ BCR-ABL1 Major IS Detection Kit (Optolane) and QXDx™ BCR-ABL %IS Kit (Bio-Rad) in Chronic Myeloid Leukemia Patients
RecruitingOBSERVATIONAL
Enrollment
80
Participants
Timeline
Start Date
March 20, 2024
Primary Completion Date
March 30, 2024
Study Completion Date
July 30, 2024
Conditions
Chronic Myelogenous Leukemia
Trial Locations (1)
10700
RECRUITING
Siriraj hospital, Bangkok
All Listed Sponsors
lead
Siriraj Hospital
OTHER
NCT06301321 - The Evaluation and Comparison of BCR-ABL p210 mRNA Transcripts (%IS Unit) Results Between Dr. PCR™ BCR-ABL1 Major IS Detection Kit (Optolane) and QXDx™ BCR-ABL %IS Kit (Bio-Rad) in Chronic Myeloid Leukemia Patients | Biotech Hunter | Biotech Hunter